• General Surgery
  • Transplant
  • American Board of Surgery
  • Indiana University School of Medicine, Medical School
  • Mcgaw Medical Center of Northwestern University
  • Mayo Graduate School of Medicine




  1. Schold JD, Buccini LD, Phelan MP, Jay CL, Goldfarb DA, Poggio ED, Sedor JR. Building an Ideal Quality Metric for ESRD Healthcare Delivery Clinical Journal of the American Society of Nephrology 2017 May.
  2. Jay CL, Schold JD.. Measuring Transplant Center Performance: The Goals are not Controversial, but the Methods and Consequences can be. Current Transplant Reports 2017 Mar;4(1):52-58.
  3. Jay CL, Skaro AI. Comparative effectiveness research in liver transplantation: crossing the cost and quality chasm. J Comp Eff Res 2013 Jan;2(1):7-9.
  4. Gordon EJ, Daud A, Caicedo JC, Cameron KA, Jay C, Fryer J, Beauvais N, Skaro A, Baker T, Jay CL. Informed consent and decision-making about adultto-adult living donor liver transplantation: a systematic review of empirical research. Transplantation 2011 Dec;92(12):1285-1296.
  5. Skaro AI, Jay CL, Ladner D, Abecassis MM. Trends in donation after cardiac death and donation after brain death--reading between the lines. Am J Transplant 2010 Nov;10(11):2390-2391.

Journal Article

  1. Jay CL, Washburn K, Dean PG, Helmick RA, Pugh JA, Stegall MD. Survival Benefit in Older Patients Associated with Earlier Transplant with High KDPI Kidneys Transplantation 2016 Aug;101(4):867-872.
  2. Jay CL, Dean PG, Helmick RA, Stegall MD. Reassessing Preemptive Kidney Transplantation in the United States: Are we making progress? Transplantation 2016 May;100(5):1120-1127.
  3. Chang Y, Gallon L, Shetty K, Chang Y, Jay C, Levitsky J, Ho B, Baker T, Ladner D, Friedewald J, Abecassis M, Hazen G, Skaro AI, Jay CL. Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies. Transplantation 2015 Feb;99(2):424-430.
  4. Chang Y., Gallon L., Jay C., Shetty K., Ho B., Levitsky J., Baker T., Ladner D., Friedewald J., Abecassis M., Hazen G., Skaro A.. Comparative Effectiveness of Liver Transplant Strategies for End-stage Liver Disease Patients on Renal Replacement Therapy Liver Transplantation 2014 Sep;20(9):1034-1044.
  5. Jay CL. Skaro AI. Ladner DP. Wang E. Lyuksemburg V. Chang Y. Xu H. Talakokkla S. Parikh N. Holl JL. Hazen GB. Abecassis MM. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit Liver Transplantation 2012 Jun;18(6):630-640.
  6. Jay C. Ladner D. Wang E. Lyuksemburg V. Kang R. Chang Y. Feinglass J. Holl JL. Abecassis M. Skaro AI. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry Journal of Hepatology 2011 Oct;55(4):808-813.
  7. Jay CL. Lyuksemburg V. Ladner DP. Wang E. Caicedo JC. Holl JL. Abecassis MM. Skaro AI. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Annals of Surgery 2011 Feb;253(2):259-264.
  8. Baker TB, Jay CL, Fryer JP, Abecassis MM. Transplant renoportal vein conduit for complete mesenteric thrombosis: a case report. Am Surg 2010 Sep;76(9):1016-1019.
  9. Jay CL, Skaro AI, Kang R, Lyuksemburg V, Preczewski L, Stroupe K, Holl JL, Abecassis MM. The increased costs of donation after cardiac death liver transplantation: caveat emptor Annals of Surgery 2010 Apr;251(4):743-748.
  10. Jay CL, Butt Z, Ladner DP, Skaro AI, Abecassis MM. A review of quality of life instruments used in liver transplantation. J Hepatol 2009 Nov;51(5):949-959.
  11. Skaro AI, Jay CL, Baker TB, Wang E, Pasricha S, Lyuksemburg V, Martin JA, Feinglass JM, Preczewski LB, Abecassis MM. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery 2009 Oct;146(4):543-552.
  12. Jay CL, Baker TB, Ladner DP, Preczewski LB, Clark L, Holl JL, Abecassis MM. Laparoscopy-assisted and open living donor right hepatectomy: a comparative study of outcomes Surgery 2009 Oct;146(4).
  13. Sandoval JA, Hoelz DJ, Woodruff HA, Powell RL, Jay CL, Grosfeld JL, Hickeyd RJ, Malkas LH. Novel peptides secreted from human neuroblastoma: useful clinical tools? J Pediatr Surg 2006 Jan;41(1):245-251.
  14. Escobar MA, Jay CL, Brooks RM, West KW, Rescorla FJ, Molleston JP, Grosfeld JL. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2006 Jan;41(1):99-103.
  15. Escobar MA, Grosfeld JL, Burdick JJ, Powell RL, Jay CL, Wait AD, West KW, Billmire DF, Scherer LR, Engum SA, Rouse TM, Ladd AP, Rescorla FJ. Surgical considerations in cystic fibrosis: a 32-year evaluation of outcomes. Surgery 2005 Oct;138(4):560-571.

Verified Patient Reviews